Differential activation of p53 by the various adducts of mitomycin C. (Q38363626)

2 September 2017

title

Differential activation of p53 by the various adducts of mitomycin C. (English)

1 reference

2 September 2017

Tarek Abbas

1 reference

2 September 2017

Magali Olivier

1 reference

2 September 2017

Jaqueline Lopez

1 reference

2 September 2017

Sandra Houser

1 reference

2 September 2017

Gu Xiao

1 reference

2 September 2017

Gopinatha Suresh Kumar

1 reference

2 September 2017

Maria Tomasz

1 reference

2 September 2017

Jill Bargonetti

1 reference

2 September 2017

language of work or name

English

0 references

publication date

14 August 2002

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

inferred from page(s)

published in

1 reference

2 September 2017

volume

277

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

40513-40519

1 reference

Nuclear accumulation of p53 in response to treatment with DNA-damaging agents

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

DNA adduct levels associated with p53 induction and delay of MCF-7 cells in S phase after exposure to benzo[g]chrysene dihydrodiol epoxide enantiomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Eukaryotic gene transcription with purified components

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

DNA interstrand cross-links induce futile repair synthesis in mammalian cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

p73 is transcriptionally regulated by DNA damage, p53, and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

DNA crosslinking, sister-chromatid exchange and specific-locus mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

p53 status and the efficacy of cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205495200

21 January 2018

Identifiers

DOI

10.1074/JBC.M205495200

1 reference

2 September 2017

1 reference